E

Enlivex Therapeutics Ltd

ENLV

1.33000
USD
-0.01
(-0.75%)
Market Closed
Volume
110
EPS
0
Div Yield
0
P/E
-1
Market Cap
28,470,021
Related Instruments
A
AVXL
-0.21000
(-3.09%)
6.58500 USD
B
BLRX
-0.09800
(-12.41%)
0.69200 USD
B
BNGO
-0.05270
(-8.23%)
0.58760 USD
B
BTAI
-0.09000
(-8.04%)
1.03000 USD
G
GRTS
-0.02140
(-3.56%)
0.57930 USD
T
TRVN
-0.00830
(-3.91%)
0.20390 USD
V
VBIV
-0.00920
(-7.34%)
0.11610 USD
Z
ZOM
-0.00010
(-0.07%)
0.14950 USD
News

Title: Enlivex Therapeutics Ltd

Sector: Healthcare
Industry: Biotechnology
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.